Therapeutic Substances Bill, 1932
Public bill · Government · Introduced
Manufacturers would need licences to produce covered medicines for sale, and the medicines would have to meet official standards for strength, quality and purity. Imports would generally require approval, with routes for research and urgent treatment; inspections and rules on labels, manufacture dates and containers would help oversee their safety and sale. The measures cover vaccines and related products, salvarsan and similar treatments, insulin, and certain injectable pituitary preparations, aiming to reduce the risk of unreliable or improperly made medicines.
Last updated 12 April 2018
- Minister for Local Government and Public Health Primary
- First StageDáil
- Second StageDáil
- Committee StageDáil
- Report StageDáil
- Fifth StageDáil
- Second StageSeanad
- Committee StageSeanad
- Report StageSeanad
- Fifth StageSeanad Enacted
- EnactedEnacted
- Therapeutic Substances Bill, 1932—Message from Dáil. Seanad
- In Committee on Finance. - Therapeutic Substances Bill, 1932—From the Seanad. Dáil
- Public Business. - Therapeutic Substances Bill, 1932—Report Stage. Seanad
- Therapeutic Substances Bill, 1932. Seanad
- Public Business. - Therapeutic Substances Bill, 1932—Second Stage. Seanad
- Therapeutic Substances Bill, 1932—Money Resolution. - (In Committee on Finance). Dáil
- Therapeutic Substances Bill, 1932—Money Resolution. - Therapeutic Substances Bill, 1932—Committee Stage. Dáil
- Therapeutic Substances Bill, 1932—First Stage. Dáil